The businesses that survive the current regulatory wave would be the kinds that moved into the controlled market before The grey market collapsed. Certified compounding pharmacies. Telehealth platforms with actual medical doctor oversight. Brands pursuing good FDA pathways.This is not the top of peptide accessibility. The February 2026 reclassifica